“The first licensed product, from Teva Pharmaceuticals USA, is for the treatment of Wilson's disease in Japan. This transaction was negotiated and completed by Paul Michaels.”
Dude is negotiating transactions with Teva, a multi billion big board company and we are to be selling here. See ya near $0.03 later today!
News 
Market Data 
Discover 
AI
